Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery

This study has been completed.
BioInvent International AB
Information provided by (Responsible Party):
ThromboGenics Identifier:
First received: November 18, 2008
Last updated: April 4, 2014
Last verified: April 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2010
  Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)